SHENZHEN, China--(BUSINESS WIRE)--Tongjitang Chinese Medicines Company (“Tongjitang”), a Cayman Islands-incorporated specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, announced today that it intends to conduct an initial public offering of 9,865,000 American depositary shares (“ADSs”), representing 39,460,000 ordinary shares of the company. The price range for the offering is between US$15.00 and US$17.00 per ADS. Each ADS represents four ordinary shares. Tongjitang has applied to list its ADSs on the New York Stock Exchange under the symbol “TCM.”
